Unknown

Dataset Information

0

Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-?1/Smads and PI3K/Akt pathways.


ABSTRACT: The aim of this study was to investigate the effect of quercetin on hepatic fibrosis, a characteristic response to acute or chronic liver injury. Mice were randomized to bile duct ligation (BDL) or carbon tetrachloride (CCl4) cirrhosis models. Quercetin (100?mg/kg or 200?mg/kg daily) was administered by gavage for 2 or 4 weeks. Liver tissue and blood samples were collected for histological and molecular analysis. The results of our experiments showed that quercetin reduced BDL or CCl4 liver fibrosis, inhibited extracellular matrix formation, and regulated matrix metallopeptidase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1. Quercetin attenuated liver damage by suppressing the TGF-?1/Smads signaling pathway and activating the PI3K/Akt signaling pathway to inhibit autophagy in BDL- or CCl4- induced liver fibrosis. Quercetin prevented hepatic fibrosis by attenuating hepatic stellate cell activation and reducing autophagy through regulating crosstalk between the TGF-?1/Smads and PI3K/Akt pathways.

SUBMITTER: Wu L 

PROVIDER: S-EPMC5571156 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways.

Wu Liwei L   Zhang Qinghui Q   Mo Wenhui W   Feng Jiao J   Li Sainan S   Li Jingjing J   Liu Tong T   Xu Shizan S   Wang Wenwen W   Lu Xiya X   Yu Qiang Q   Chen Kan K   Xia Yujing Y   Lu Jie J   Xu Ling L   Zhou Yingqun Y   Fan Xiaoming X   Guo Chuanyong C  

Scientific reports 20170824 1


The aim of this study was to investigate the effect of quercetin on hepatic fibrosis, a characteristic response to acute or chronic liver injury. Mice were randomized to bile duct ligation (BDL) or carbon tetrachloride (CCl<sub>4</sub>) cirrhosis models. Quercetin (100 mg/kg or 200 mg/kg daily) was administered by gavage for 2 or 4 weeks. Liver tissue and blood samples were collected for histological and molecular analysis. The results of our experiments showed that quercetin reduced BDL or CCl<  ...[more]

Similar Datasets

| S-EPMC4466688 | biostudies-literature
| S-EPMC7294126 | biostudies-literature
| S-EPMC8063466 | biostudies-literature
| S-EPMC8051749 | biostudies-literature
| S-EPMC6711851 | biostudies-literature
| S-EPMC6738525 | biostudies-literature
| S-EPMC7243025 | biostudies-literature
| S-EPMC6912224 | biostudies-literature
| S-EPMC9649626 | biostudies-literature
| S-EPMC8654182 | biostudies-literature